Praxis Initiates Patient Recruitment Campaign for Multiple Medical Research Studies for Women with Sexual Dysfunction

Brentwood, TN — July 12, 2006 — Praxis, a company specializing in centralized patient recruitment for clinical research studies, is providing marketing communications services to a major pharmaceutical company for several clinical research studies.  The clinical studies are designed to explore the use of an investigational oral medication to be used in the treatment of female sexual dysfunction.

According to a survey by the Journal of the American Medical Association, about 40 million women have some type of sexual disorder.  Other research has shown that female sexual dysfunction affects more than 20 - 50% of the female population in the U.S. 

Praxis is providing a variety of patient recruitment services to help the sponsor achieve their randomization goals for the clinical program.  Recruitment strategies and materials consist of a combination of targeted tactics including an informational website, direct marketing, local radio advertising and patient education materials.  The program is managed through the centralized recruitment center via PraxisDirect®, the proprietary study management technology developed by Praxis.  PraxisDirect delivers real-time patient recruitment statistics, tracking data and other performance analyses 24-hours a day, through a unique, password protected website that will be customized to this study. 

“These studies are part of several we are working on within the female health sector.  This segment continues to grow as more organizations both public and private are dedicated solely to female health issues, and the medical community recognizes the need to provide a wider range of health services that focus on women.” said David Fox, president and CEO of Praxis.  “Our expertise in this field and our strategic marketing approach will greatly enhance and generate awareness of these studies in each sites’ local community and help accelerate patient recruitment.”

The clinical program consists of a several 32-week, Phase III studies.  The studies will take place at nearly 200 sites in both the U.S. and Canada.    

Praxis Communications, Inc., headquartered in Brentwood, TN, provides the pharmaceutical and biotech industries with a wide range of services for patient recruitment and retention for clinical trials including patient profiling, recruitment planning, centralized fulfillment, media relations, advertising, and program management.  For more information, call Praxis at (615) 312-8207. 

> Back to Press Releases